2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 28332433 | The cost-effectiveness of alectinib in anaplastic lymphoma kinase-positive (ALK+) advanced NSCLC previously treated with crizotinib. | 2017 Jul | 1 |
| 2 | 25548525 | Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review. | 2015 | 1 |